MANSFIELD — Roche Bros Supermarkets Inc., a 20-store eastern Massachusetts grocery chain under the Roche Bros., Sudbury Farms and Brothers Marketplace banners, said it has entered into a ...
An electric motorcycle, made by Swedish-Kenyan manufacturer Roam completed a 6,000-kilometer (3,700-mile) journey from Nairobi, Kenya, to Stellenbosch, South Africa, in 17 days, using only solar ...
The best OnePlus phone yet also has a flagship BOE display, an IP69 ingress protection rating, and a larger 6,000 mAh silicon carbon battery. While the OnePlus 13 is launched in China first ...
I also tracked the walk using the Strava app on my iPhone 12 Mini for additional data. 6,000 steps and almost an hour to the dot later, I returned to my front doorstep and checked the results of ...
A County Durham A1(M) speed camera has caught nearly 6,000 drivers over the last year and is one of the UK's top 20 'hotspots' for catching motorists over the speed limit. The speed camera on ...
Here’s how it works. Ultra runner David Roche got back on the course this weekend to prove that his Leadville 100 win was no fluke. The runner snatched victory at The Javelina Jundred yesterday, just ...
After forming a gene therapy partnership with Dyno Therapeutics in 2020, Roche is back for more. In a new deal potentially worth more than $1 billion, Roche is paying Dyno $50 million upfront to ...
With an upfront payment of $50 million from Roche, the partnership will leverage Dyno Therapeutics’ in vivo gene therapy delivery technology, which synthesizes virus capsids with better functionality ...
Roche CEO: not good to limit competition in this space Roche says not itself, but others affected by Catalent deal Swiss drugmaker joins US peer Lilly in voicing opposition Eli Lilly and advocacy ...
Speaking to the press Wednesday, Roche’s chief executive Thomas Schinecker critiqued the proposed transaction, arguing that it could hamper the ability of smaller biopharma players to lock down ...
Roche doesn’t think so. “I think we don’t see anything that should be slowing Vabysmo momentum down,” Teresa Graham, CEO of Roche Pharmaceuticals, said during a press conference Wednesday ...
UCB will ad­vance its an­ti-tau an­ti­body for Alzheimer’s dis­ease so­lo af­ter Roche and Genen­tech walked away from the as­set known as bepranemab.